vs
Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and OneWater Marine Inc. (ONEW). Click either name above to swap in a different company.
Amneal Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($722.5M vs $442.3M, roughly 1.6× OneWater Marine Inc.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs -2.9%, a 13.7% gap on every dollar of revenue. On growth, Amneal Pharmaceuticals, Inc. posted the faster year-over-year revenue change (3.9% vs -8.5%). Over the past eight quarters, OneWater Marine Inc.'s revenue compounded faster (8.2% CAGR vs 1.5%).
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
OneWater Marine Inc. is a leading recreational marine retailer headquartered in the U.S. It sells new and pre-owned boats, yachts and marine parts, offers maintenance, repair and financing services, and serves individual and commercial leisure boating customers across North America through its extensive network of local dealerships.
AMRX vs ONEW — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $722.5M | $442.3M |
| Net Profit | $78.0M | $-12.9M |
| Gross Margin | 44.3% | 23.9% |
| Operating Margin | 19.6% | 1.7% |
| Net Margin | 10.8% | -2.9% |
| Revenue YoY | 3.9% | -8.5% |
| Net Profit YoY | 410.5% | — |
| EPS (diluted) | $0.19 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $442.3M | ||
| Q1 26 | $722.5M | $380.6M | ||
| Q4 25 | $814.3M | $380.6M | ||
| Q3 25 | $784.5M | $460.1M | ||
| Q2 25 | $724.5M | $552.9M | ||
| Q1 25 | $695.4M | $483.5M | ||
| Q4 24 | $730.5M | $375.8M | ||
| Q3 24 | $702.5M | $377.9M |
| Q2 26 | — | $-12.9M | ||
| Q1 26 | $78.0M | $-7.7M | ||
| Q4 25 | $35.1M | $-7.7M | ||
| Q3 25 | $2.4M | $-113.0M | ||
| Q2 25 | $22.4M | $10.7M | ||
| Q1 25 | $12.2M | $-368.0K | ||
| Q4 24 | $-31.1M | $-12.0M | ||
| Q3 24 | $-156.0K | $-9.2M |
| Q2 26 | — | 23.9% | ||
| Q1 26 | 44.3% | 23.5% | ||
| Q4 25 | 36.5% | 23.5% | ||
| Q3 25 | 34.9% | 22.6% | ||
| Q2 25 | 39.5% | 23.3% | ||
| Q1 25 | 36.8% | 22.8% | ||
| Q4 24 | 36.0% | 22.4% | ||
| Q3 24 | 38.4% | 24.0% |
| Q2 26 | — | 1.7% | ||
| Q1 26 | 19.6% | — | ||
| Q4 25 | 13.8% | -1.4% | ||
| Q3 25 | 9.0% | -28.3% | ||
| Q2 25 | 15.4% | 5.5% | ||
| Q1 25 | 14.4% | 3.4% | ||
| Q4 24 | 10.4% | -0.5% | ||
| Q3 24 | 12.6% | 1.2% |
| Q2 26 | — | -2.9% | ||
| Q1 26 | 10.8% | -2.0% | ||
| Q4 25 | 4.3% | -2.0% | ||
| Q3 25 | 0.3% | -24.5% | ||
| Q2 25 | 3.1% | 1.9% | ||
| Q1 25 | 1.8% | -0.1% | ||
| Q4 24 | -4.3% | -3.2% | ||
| Q3 24 | -0.0% | -2.4% |
| Q2 26 | — | $-0.78 | ||
| Q1 26 | $0.19 | $-0.47 | ||
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $0.04 | — | ||
| Q4 24 | $-0.10 | — | ||
| Q3 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $197.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $269.4M |
| Total Assets | $3.5B | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | $197.7M | — | ||
| Q4 25 | $282.0M | — | ||
| Q3 25 | $201.2M | — | ||
| Q2 25 | $71.5M | — | ||
| Q1 25 | $59.2M | — | ||
| Q4 24 | $110.6M | — | ||
| Q3 24 | $74.0M | — |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — |
| Q2 26 | — | $269.4M | ||
| Q1 26 | — | $277.5M | ||
| Q4 25 | $-70.8M | $277.5M | ||
| Q3 25 | $-109.5M | $285.0M | ||
| Q2 25 | $-112.1M | $393.2M | ||
| Q1 25 | $-131.7M | $381.6M | ||
| Q4 24 | $-109.3M | $354.8M | ||
| Q3 24 | $-93.4M | $360.8M |
| Q2 26 | — | $1.4B | ||
| Q1 26 | $3.5B | $1.4B | ||
| Q4 25 | $3.7B | $1.4B | ||
| Q3 25 | $3.6B | $1.4B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $3.4B | $1.6B | ||
| Q4 24 | $3.5B | $1.6B | ||
| Q3 24 | $3.5B | $1.6B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRX
Segment breakdown not available.
ONEW
| New boat | $272.0M | 62% |
| Pre-owned boat | $94.4M | 21% |
| Service, parts & other | $61.9M | 14% |
| Finance & insurance income | $14.0M | 3% |
